Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
ISTH 2025
Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 study
ISTH 2025
ISTH 2025
21 - 25 June 2025
Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 study
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Share
Copy link
{{pageUrl}}
Keywords
Rare Blood Disorders
Congress oral presentation
Concizumab
